148 related articles for article (PubMed ID: 22612617)
1. Future long-term trials of postmenopausal hormone replacement therapy - what is possible and what is the optimal protocol and regimen?
Purbrick B; Stranks K; Sum C; MacLennan AH
Climacteric; 2012 Jun; 15(3):288-93. PubMed ID: 22612617
[TBL] [Abstract][Full Text] [Related]
2. Have we come full circle - or moved forward? The Women's Health Initiative 10 years on.
Langer RD; Manson JE; Allison MA
Climacteric; 2012 Jun; 15(3):206-12. PubMed ID: 22612605
[TBL] [Abstract][Full Text] [Related]
3. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy in postmenopausal women.
Yasui T; Uemura H; Takikawa M; Irahara M
J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
[TBL] [Abstract][Full Text] [Related]
6. New products and regimens (since 2003).
Panay N
Climacteric; 2007 Oct; 10 Suppl 2():109-14. PubMed ID: 17882685
[TBL] [Abstract][Full Text] [Related]
7. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
8. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
Brinton RD
Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
[TBL] [Abstract][Full Text] [Related]
9. Effects of hormone replacement therapy on cognitive aging and dementia risk in postmenopausal women: a review of ongoing large-scale, long-term clinical trials.
Zec RF; Trivedi MA
Climacteric; 2002 Jun; 5(2):122-34. PubMed ID: 12051107
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal hormone therapy: cardiovascular risks.
Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
[TBL] [Abstract][Full Text] [Related]
11. A comparative review of the risks and benefits of hormone replacement therapy regimens.
Warren MP
Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
[TBL] [Abstract][Full Text] [Related]
12. [What scientific and clinical findings will result from the controlled trial "Women's Health Initiative"?].
Gaspard U
Bull Mem Acad R Med Belg; 2003; 158(1-2):133-41; discussion 141-5. PubMed ID: 12852099
[TBL] [Abstract][Full Text] [Related]
13. [Cardiovascular effects of selective estrogen receptor modulators. Current perspectives].
Simoncini T; Mannella P; Genazzani AR
Recenti Prog Med; 2003 Feb; 94(2):51-6. PubMed ID: 12908369
[TBL] [Abstract][Full Text] [Related]
14. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
Reginster JY
J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
[TBL] [Abstract][Full Text] [Related]
15. Postmenopausal hormone use in women with acute coronary syndromes.
Parsons E; Newby LK; Bhapkar MV; Alexander KP; White HD; Shah SH; Bushnell CD; Califf RM;
J Womens Health (Larchmt); 2004 Oct; 13(8):863-71. PubMed ID: 15671702
[TBL] [Abstract][Full Text] [Related]
16. Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review.
Abramson BL
J Cardiovasc Risk; 2002 Dec; 9(6):309-14. PubMed ID: 12478199
[TBL] [Abstract][Full Text] [Related]
17. Evidence-based assessment of the impact of the WHI on women's health.
Burger HG; MacLennan AH; Huang KE; Castelo-Branco C
Climacteric; 2012 Jun; 15(3):281-7. PubMed ID: 22612616
[TBL] [Abstract][Full Text] [Related]
18. Lessons learned from the WHI: HRT requires a cautious and individualized approach.
Aubuchon M; Santoro N
Geriatrics; 2004 Nov; 59(11):22-6. PubMed ID: 15615157
[TBL] [Abstract][Full Text] [Related]
19. What's new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone.
Simon JA
Climacteric; 2012 Apr; 15 Suppl 1():3-10. PubMed ID: 22432810
[TBL] [Abstract][Full Text] [Related]
20. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
L'hermite M; Simoncini T; Fuller S; Genazzani AR
Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
